Stay updated on Abatacept Post-marketing Clinical Trial in Japan
Sign up to get notified when there's something new on the Abatacept Post-marketing Clinical Trial in Japan page.

Latest updates to the Abatacept Post-marketing Clinical Trial in Japan page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedAdded new MedlinePlus Genetics topic on Rheumatoid arthritis. Overall meaning: the page expands its medical genetics content with a focus topic on rheumatoid arthritis.SummaryDifference0.3%

- Check22 days agoChange DetectedAdded a government funding notice and updated version to v3.2.0; removed the older MedlinePlus Genetics topic and older revision tag v3.1.0.SummaryDifference5%

- Check29 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0.SummaryDifference0.1%

- Check36 days agoChange DetectedAdded a new MedlinePlus Genetics topic: Rheumatoid arthritis. No deletions observed.SummaryDifference0.3%

- Check43 days agoChange DetectedVersion updated to v3.0.2; removed the MedlinePlus Genetics topic 'Rheumatoid arthritis' and the 'Back to Top' link, and the previous v3.0.1 reference is gone.SummaryDifference0.6%

- Check51 days agoChange DetectedThe web page has been updated to include information on Rheumatoid arthritis under MedlinePlus Genetics topics, and the version has been revised from v3.0.0 to v3.0.1.SummaryDifference0.6%

Stay in the know with updates to Abatacept Post-marketing Clinical Trial in Japan
Enter your email address, and we'll notify you when there's something new on the Abatacept Post-marketing Clinical Trial in Japan page.